Avience Biomedicals Ltd vs Gaudium Ivf And Women Health Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Nov 01, 2026

Key Highlights

The Latest Trading Price of Avience Biomedicals Ltd is ₹ 253.15 as of 30 Oct 15:30 . The P/E Ratio of Avience Biomedicals Ltd changed from 0 on March 2024 to 0 on March 2023 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Gaudium IVF and Women Health Ltd changed from 21.2 on March 2026 to 0 on March 2023 . This represents a CAGR of -100.00% over 3 years The Market Cap of Avience Biomedicals Ltd changed from ₹ 0 crore on March 2024 to ₹ 0 crore on March 2023 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Gaudium IVF and Women Health Ltd changed from ₹ 519.04 crore on March 2026 to ₹ 0 crore on March 2023 . This represents a CAGR of -100.00% over 3 years The revenue of Avience Biomedicals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Gaudium IVF and Women Health Ltd for the Jun '26 is ₹ 20.5 crore as compare to the Mar '26 revenue of ₹ 30.53 crore. This represent the decline of -32.85% The ebitda of Avience Biomedicals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Gaudium IVF and Women Health Ltd for the Jun '26 is ₹ 3.55 crore as compare to the Mar '26 ebitda of ₹ 12.35 crore. This represent the decline of -71.26% The net profit of Avience Biomedicals Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Gaudium IVF and Women Health Ltd changed from ₹ 3.4 crore to ₹ 1.78 crore over 7 quarters. This represents a CAGR of -30.91% The Dividend Payout of Avience Biomedicals Ltd changed from 0 % on March 2022 to 0 % on March 2026 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Gaudium IVF and Women Health Ltd changed from 47.88 % on March 2023 to 0 % on March 2026 . This represents a CAGR of -100.00% over 4 years .

About Avience Biomedicals Ltd

Avience Biomedicals Limited was originally incorporated as Private Limited Company as 'Avience Biomedicals Private Limited' on December 23, 2019 with the Registrar of Companies, Delhi.
Later, Company's status got converted into a Public Limited Company, the name of the Company was changed to 'Avience Biomedicals Limited' and fresh Certificate of incorporation dated September 3, 2024, was issued by the Registrar of Companies, Delhi. Avience Biomedicals Limited is a medical consumable company dedicated to manufacturing of Vitro-Diagnostic (IVD) products and medical devices in Noida, Uttar Pradesh, India.
In vitro diagnostics (IVDs) are tests that can detect disease, conditions and infections. The Company commenced its journey by producing essential diagnostic kits like Viral Transport Media (VTM), Covid, Human Immunodeficiency Viruses (HIV), HBs AG, Malaria, Dengue and others aimed at aiding medical institutions with affordable and good-quality solutions.

About Gaudium IVF and Women Health Ltd

Gaudium IVF and Women Health Limited was originally incorporated in the name of 'Gaudium IVF and Women Health Private Limited' as a Private Limited Company, dated March 24, 2015 with the RoC, Delhi and Haryana.
Subsequently, the status of the Company was converted from a Private Limited into a Public Limited and the name was changed to Gaudium IVF and Women Health Limited', and a fresh Certificate of Incorporation dated October 24, 2024 was issued by the Central Processing Center. Company is engaged in IVF (In vitro fertilization) treatment in India and has grown into several states with Hub and spoke model over the years.
Gaudium IVF is founded by the Promoter Dr. Manika Khanna, a specialist with advanced training in gynecological endoscopic surgery from Kiel, Germany, and in Gynaec Endoscopy from Melbourne IVF Gujarat Private Limited.

FAQs for the comparison of Avience Biomedicals Ltd and Gaudium IVF and Women Health Ltd

Which company has a larger market capitalization, Avience Biomedicals Ltd or Gaudium IVF and Women Health Ltd?

Market cap of Avience Biomedicals Ltd is 138 Cr while Market cap of Gaudium IVF and Women Health Ltd is 769 Cr

What are the key factors driving the stock performance of Avience Biomedicals Ltd and Gaudium IVF and Women Health Ltd?

The stock performance of Avience Biomedicals Ltd and Gaudium IVF and Women Health Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Avience Biomedicals Ltd and Gaudium IVF and Women Health Ltd?

As of November 1, 2026, the Avience Biomedicals Ltd stock price is INR ₹253.15. On the other hand, Gaudium IVF and Women Health Ltd stock price is INR ₹105.75.

How do dividend payouts of Avience Biomedicals Ltd and Gaudium IVF and Women Health Ltd compare?

To compare the dividend payouts of Avience Biomedicals Ltd and Gaudium IVF and Women Health Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.